Significantly, ECD KD led to an increase in the expression of herstatin, a tumor suppressor splice variant (58, –, 60), but a reduction in the expression of the Δ16HER2 variant, a prooncogenic splice variant (57, 61, 62). The gene discussed is ERBB2; the disease is neoplasm.